Syena Overview

  • Status
  • Private

  • Latest Deal Type
  • Joint Venture

  • Financing Rounds
  • 1

Syena General Information

Description

Developer of cancer therapy machine intended to develop T-cell receptor (TCR) natural killer (NK) cell therapies. The company's products include cancer therapy technology, enabling clinics to provide compelling new cell therapy options for patients in need.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • United States
Primary Industry
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Syena Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Syena‘s full profile, request access.

Request a free trial

Syena Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Syena‘s full profile, request access.

Request a free trial

Syena FAQs

  • Where is Syena headquartered?

    Syena is headquartered in .

  • What industry is Syena in?

    Syena’s primary industry is Biotechnology.

  • Is Syena a private or public company?

    Syena is a Private company.

  • What is Syena’s current revenue?

    The current revenue for Syena is .

  • Who are Syena’s investors?

    Replay (Drug Discovery) and UT MD Anderson have invested in Syena.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process